首页>
外国专利>
ANTIMICROBIAL PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF
ANTIMICROBIAL PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF
展开▼
机译:Scylla Paramamosain的抗微生物肽ScyreRocin及其方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure discloses an antimicrobial peptide Scyreprocin of Scylla paramamosain and a method thereof, wherein an amino acid sequence of the antimicrobial peptide Scyreprocin comprises a sequence shown in SEQ ID NO 01, and the antimicrobial peptide is expressed and purified by using genetic engineering technology. The recombinant antimicrobial peptide Scyreprocin has advantages of wide antimicrobial spectrum, good antimicrobial effect, and rapid germicidal rate, shows great application significance, and has good application in preparation of antimicrobial agents. The recombinant antimicrobial peptide Scyreprocin has no cytotoxicity to mouse hepatocytes AML12, human liver cells L02, and can be safely used for medical treatment or can be used as a feed composition.
展开▼
机译:本公开公开了一种抗微生物肽的Scylla paramamosain的抗微生物肽Scyregocin及其方法,其中抗微生物肽Scyreprocin的氨基酸序列包含SEQ ID NO 01中所示的序列,并且通过使用基因工程技术表达和纯化抗微生物肽。 重组抗微生物肽ScyreRocin具有广泛的抗微生物谱,良好的抗菌效果和快速杀菌率的优点,具有很大的应用意义,并且在制备抗微生物剂方面具有良好的应用。 重组抗微生物肽ScyreRocin对小鼠肝细胞AML12,人肝细胞L02没有细胞毒性,并且可以安全地用于医疗或可用作进料组合物。
展开▼